By Dr Brooke Anne Pereira

Preprints

Wu S; Roden D; Wang C; Holliday H; Harvey K; Cazet A; Murphy K; Pereira B; Al-Eryani G; Bartonicek N; Hou R; Torpy J; Junankar S; Chan C-L; Lam E; Hui M; Gluch L; Beith J; Parker A; Robbins E; Segara D; Mak C; Cooper C; Warrier S; Forrest A; Powell J; O’Toole S; Cox T; Timpson P; Lim E; Liu S; Swarbrick A, 2020, Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer, http://dx.doi.org/10.1101/2020.06.04.135327

Maraszek KE; Tisdale AA; Reavis HD; Liu X; Gomez EC; Dolskii A; Brown C; Thakkar D; Dungan M; Adhikari A; Mackey E; Franco-Barraza J; Pereira BA; Timpson P; Tang DG; Steele N; Cukierman E; Feigin ME, A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancer, http://dx.doi.org/10.64898/2026.05.20.726559

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey S; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill A; Gonzales-Aloy E; Kokkinos J; Gebski V; Turner N; Apte M; Davis TP; Morton JP; Haghighi K; Initiative APCG; Phillips PA, Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition, http://dx.doi.org/10.1101/2020.07.12.199638

Murphy KJ; Chambers CR; Reed DA; Channon LM; Mills NE; McKay SE; Lee V; Howell AE; Tran AM; Nobis M; Magenau A; Stoehr J; Pereira BA; Kuepper N; Ritchie S; Gordon K; Trpceski M; Tyma VM; Hafiz S; Johri V; Ang A; Barkauskas DS; Vennin C; Wang XQ; Naeini MM; Meyer B; Parker AL; Gummadi S; Chitti SV; Fajardo DC; Zaratzian A; Tayao M; Da Silva A; Initiative APG; Atlas APM; Cesare AJ; Mathivanan S; Stirzaker C; Latham SL; Croucher DR; Sharbeen G; Phillips PA; Goldstein LD; Lyons RJ; Nagrial A; Pavlakis N; Gill AJ; Biankin AV; Samra J; Caldon CE; Evans TRJ; Chantrill L; Horvath LG; Sansom OJ; Morton JP; Phan TG; Wang Y; Cock T-A; Kinkel SA; Bishop A; Devlin M; Lambert J; Cox TR; Pajic M; Burns CJ; Herrmann D; Timpson P, Pulsed priming with the FAK inhibitor narmafotinib enhances both gemcitabine/Abraxane and FOLFIRINOX chemotherapy response in pancreatic cancer, http://dx.doi.org/10.64898/2026.07.23.740234

Reed DA; Howell AE; Kuepper N; Tran AMH; Magenau A; Barkauskas DS; Nobis M; Chambers CR; Lee V; Channon LM; Zhu J; Ritchie S; Stoehr J; Wylie K; Chen J; Attwater D; Harvey K; Wu SZ; Saw K; Lyons RJ; Zaratzian A; Tayao M; Da Silva A; Gallego-Ortega D; Gill AJ; Cox TR; Pereira BA; Murphy KJ; Morton JP; Lim E; Swarbrick A; O’Toole S; Samuel MS; Caldon CE; Zanin-Zhorov A; Timpson P; Herrmann D, ROCK2 inhibition has a dual role in reducing ECM remodelling and cell growth, while impairing migration and invasion, http://dx.doi.org/10.1101/2025.07.21.666015

Back to profile page